Will Pharmaceutical Giants Use Patents to Limit Access to COVID Drugs?

As the number of confirmed COVID-19 cases worldwide approaches 4 million and the pandemic could be with us for months or years, Democracy Now! looks at who can access drugs like remdesivir, being developed by pharmaceutical giant Gilead, which has the patent for the drug and is poised to make massive profits.

DN looks at how much drugs like remdesivir will cost, and who can access them, with writer Achal Prabhala, coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.

Democracy Now! produces a daily, global, independent news hour hosted by award-winning journalists Amy Goodman and Juan González.

Our reporting includes breaking daily news headlines and in-depth interviews with people on the front lines of the world’s most pressing issues.

On DN!, you’ll hear a diversity of voices speaking for themselves, providing a unique and sometimes provocative perspective on global events.

Missed an episode? Check out DN on FSTV VOD anytime or visit the show page for the latest clips.

#FreeSpeechTV is one of the last standing national, independent news networks committed to advancing progressive social change.

#FSTV is available on Dish, DirectTV , AppleTV, Roku, Sling and online at freespeech.org.